Breaking News, Financial News

Financial Report: Abbott

Profit jumps 12% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 4Q Revenues: $10.4 billion (+4%) 4Q Earnings: $1.6 billion (+12%) FY Revenues: $38.9 billion (+11%) FY Earnings: $4.7 billion (+2%) Comments: Proprietary Pharmaceutical sales in the quarter were $4.8 billion (+7%), and for the year grew 11% to $17.0 billion. Humira sales were $2.2 billion in the quarter (+16%), and $7.9 billion for the year (+21%). Trilipix/TriCor sales were down 4% to $483 million in the quarter and up 6% to $1.7 billion for the year. Kaletra sales were down 16% to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters